Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06323369
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2024-03-15
Brief Title:
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma
Sponsor:
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University